Found: 1
Select item for more details and to access through your institution.
Phase II pilot study of single-agent etirinotecan pegol (NKTR-102) in bevacizumab-resistant high grade glioma.
- Published in:
- Journal of Neuro-Oncology, 2015, v. 123, n. 2, p. 277, doi. 10.1007/s11060-015-1795-0
- By:
- Publication type:
- Article